Latest News

Pfizer buys biotech firm Seagen for $43 billion
Pfizer buys biotech firm Seagen for $43 billion
Business and Economy
by  AFP

US pharmaceutical giant Pfizer announced Monday that it had reached a deal to buy biotech firm Seagen, specializing in innovative cancer treatment, for $43 billion. The deal with Seagen would double Pfizer's early-stage oncology clinical pipeline, the pharmaceutical firm added.